Contact
Please use this form to send email to PR contact of this press release:
Aravive Announces FDA Orphan Drug Designation Granted to Batiraxcept for the Treatment of Pancreatic Cancer
TO:
Please use this form to send email to PR contact of this press release:
Aravive Announces FDA Orphan Drug Designation Granted to Batiraxcept for the Treatment of Pancreatic Cancer
TO: